{"title": "Common treatment for multiple sclerosis may prolong life", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/pharmaceuticals.xml", "value": "Common treatment for multiple sclerosis may prolong life"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2019/03/190318132638.htm"}], "link": "https://www.sciencedaily.com/releases/2019/03/190318132638.htm", "summary": "Researchers have found that a widely prescribed drug for multiple sclerosis (MS) is associated with longer survival for patients.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/pharmaceuticals.xml", "value": "Researchers have found that a widely prescribed drug for multiple sclerosis (MS) is associated with longer survival for patients."}, "published": "Mon, 18 Mar 2019 13:26:38 EDT", "published_parsed": [2019, 3, 18, 17, 26, 38, 0, 77, 0], "id": "https://www.sciencedaily.com/releases/2019/03/190318132638.htm", "guidislink": false}